Loading...
Chemokines as Cancer Vaccine Adjuvants
We are witnessing a new era of immune-mediated cancer therapies and vaccine development. As the field of cancer vaccines advances into clinical trials, overcoming low immunogenicity is a limiting step in achieving full success of this therapeutic approach. Recent discoveries in the many biological r...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4067044/ https://ncbi.nlm.nih.gov/pubmed/24967094 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines1040444 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|